Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Despite insurance coverage for many patients, approximately 54% of users report difficulty affording the medications ^19
GLP-1 receptor agonists are expensive medications, and without robust efficacy data for addiction treatment, their use for this indication cannot be justified from a health economics perspective
H.WangX.XuY
Exploring the wider benefits of semaglutide investigation in metabolic research [PMID: 36691307] Laboratory literature summary: Exploring the wider benefits of semaglutide investigation in metabolic research models: insight from the STEP program
US$ 22.00
US$ 22.34
US$ 21.50
US$ 23.91
US$ 27.76
US$ 26.43
